370 related articles for article (PubMed ID: 35295334)
1. Transforming Growth Factor-Beta (TGF-β) Signaling in Cancer-A Betrayal Within.
Baba AB; Rah B; Bhat GR; Mushtaq I; Parveen S; Hassan R; Hameed Zargar M; Afroze D
Front Pharmacol; 2022; 13():791272. PubMed ID: 35295334
[TBL] [Abstract][Full Text] [Related]
2. Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk.
Matise LA; Palmer TD; Ashby WJ; Nashabi A; Chytil A; Aakre M; Pickup MW; Gorska AE; Zijlstra A; Moses HL
Breast Cancer Res; 2012 Jul; 14(4):R98. PubMed ID: 22748014
[TBL] [Abstract][Full Text] [Related]
3. Exploring the extensive crosstalk between the antagonistic cytokines- TGF-β and TNF-α in regulating cancer pathogenesis.
Dash S; Sahu AK; Srivastava A; Chowdhury R; Mukherjee S
Cytokine; 2021 Feb; 138():155348. PubMed ID: 33153895
[TBL] [Abstract][Full Text] [Related]
4. TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis.
Hao Y; Baker D; Ten Dijke P
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31195692
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta in cancer and metastasis.
Jakowlew SB
Cancer Metastasis Rev; 2006 Sep; 25(3):435-57. PubMed ID: 16951986
[TBL] [Abstract][Full Text] [Related]
6. TGF-beta signaling in cancer treatment.
Fabregat I; Fernando J; Mainez J; Sancho P
Curr Pharm Des; 2014; 20(17):2934-47. PubMed ID: 23944366
[TBL] [Abstract][Full Text] [Related]
7. The Molecular Mechanism of Epithelial-Mesenchymal Transition for Breast Carcinogenesis.
Li CJ; Chu PY; Yiang GT; Wu MY
Biomolecules; 2019 Sep; 9(9):. PubMed ID: 31514467
[TBL] [Abstract][Full Text] [Related]
8. Molecular pathways: targeting the TGF-β pathway for cancer therapy.
Smith AL; Robin TP; Ford HL
Clin Cancer Res; 2012 Sep; 18(17):4514-21. PubMed ID: 22711703
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-beta promotes invasion in tumorigenic but not in nontumorigenic human prostatic epithelial cells.
Ao M; Williams K; Bhowmick NA; Hayward SW
Cancer Res; 2006 Aug; 66(16):8007-16. PubMed ID: 16912176
[TBL] [Abstract][Full Text] [Related]
10. The Bright and the Dark Side of TGF-β Signaling in Hepatocellular Carcinoma: Mechanisms, Dysregulation, and Therapeutic Implications.
Gungor MZ; Uysal M; Senturk S
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205692
[TBL] [Abstract][Full Text] [Related]
11. Duel nature of TGF-beta signaling: tumor suppressor vs. tumor promoter.
Bachman KE; Park BH
Curr Opin Oncol; 2005 Jan; 17(1):49-54. PubMed ID: 15608513
[TBL] [Abstract][Full Text] [Related]
12. [TGF-β signaling pathways in cancers].
Talar B; Czyż M
Postepy Hig Med Dosw (Online); 2013 Sep; 67():1008-17. PubMed ID: 24088545
[TBL] [Abstract][Full Text] [Related]
13. Transforming Growth Factor-β: An Agent of Change in the Tumor Microenvironment.
Stuelten CH; Zhang YE
Front Cell Dev Biol; 2021; 9():764727. PubMed ID: 34712672
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic Reprogramming of TGF-β Signaling in Breast Cancer.
Suriyamurthy S; Baker D; Ten Dijke P; Iyengar PV
Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31137748
[TBL] [Abstract][Full Text] [Related]
15. The roles of TGF-β signaling in carcinogenesis and breast cancer metastasis.
Imamura T; Hikita A; Inoue Y
Breast Cancer; 2012 Apr; 19(2):118-24. PubMed ID: 22139728
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta signaling in cancer invasion and metastasis.
Leivonen SK; Kähäri VM
Int J Cancer; 2007 Nov; 121(10):2119-24. PubMed ID: 17849476
[TBL] [Abstract][Full Text] [Related]
17. The Cain and Abl of epithelial-mesenchymal transition and transforming growth factor-β in mammary epithelial cells.
Allington TM; Schiemann WP
Cells Tissues Organs; 2011; 193(1-2):98-113. PubMed ID: 21051857
[TBL] [Abstract][Full Text] [Related]
18. Physical interaction of STAT1 isoforms with TGF-β receptors leads to functional crosstalk between two signaling pathways in epithelial ovarian cancer.
Tian X; Guan W; Zhang L; Sun W; Zhou D; Lin Q; Ren W; Nadeem L; Xu G
J Exp Clin Cancer Res; 2018 May; 37(1):103. PubMed ID: 29751820
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-β signaling in tumor initiation, progression and therapy in breast cancer: an update.
Zu X; Zhang Q; Cao R; Liu J; Zhong J; Wen G; Cao D
Cell Tissue Res; 2012 Jan; 347(1):73-84. PubMed ID: 21845401
[TBL] [Abstract][Full Text] [Related]
20. FOXQ1 mediates the crosstalk between TGF-β and Wnt signaling pathways in the progression of colorectal cancer.
Peng X; Luo Z; Kang Q; Deng D; Wang Q; Peng H; Wang S; Wei Z
Cancer Biol Ther; 2015; 16(7):1099-109. PubMed ID: 25955104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
